Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review

Botulinum toxin type B (BoNT-B), known as Myobloc(®) in the United States and as Neurobloc(®) in Europe, is a new therapeutically available serotype among the botulinum toxin family. During the last years several data have been reported in literature investigating its efficacy and safety, as well as...

Descripción completa

Detalles Bibliográficos
Autores principales: Campanati, Anna, Diotallevi, Federico, Radi, Giulia, Martina, Emanuela, Marconi, Barbara, Bobyr, Ivan, Offidani, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966525/
https://www.ncbi.nlm.nih.gov/pubmed/36828461
http://dx.doi.org/10.3390/toxins15020147
_version_ 1784897038748483584
author Campanati, Anna
Diotallevi, Federico
Radi, Giulia
Martina, Emanuela
Marconi, Barbara
Bobyr, Ivan
Offidani, Annamaria
author_facet Campanati, Anna
Diotallevi, Federico
Radi, Giulia
Martina, Emanuela
Marconi, Barbara
Bobyr, Ivan
Offidani, Annamaria
author_sort Campanati, Anna
collection PubMed
description Botulinum toxin type B (BoNT-B), known as Myobloc(®) in the United States and as Neurobloc(®) in Europe, is a new therapeutically available serotype among the botulinum toxin family. During the last years several data have been reported in literature investigating its efficacy and safety, as well as defining the dosing and application regiments of BoNT-B in the treatment of hyperhidrosis. Moreover, recent studies have been examining its safety profile, which may be different from those known about BoNT-A. The aim of this review is to provide information about what is currently known about BoNT-B in regards to the treatment of focal hyperhidrosis.
format Online
Article
Text
id pubmed-9966525
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99665252023-02-26 Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review Campanati, Anna Diotallevi, Federico Radi, Giulia Martina, Emanuela Marconi, Barbara Bobyr, Ivan Offidani, Annamaria Toxins (Basel) Review Botulinum toxin type B (BoNT-B), known as Myobloc(®) in the United States and as Neurobloc(®) in Europe, is a new therapeutically available serotype among the botulinum toxin family. During the last years several data have been reported in literature investigating its efficacy and safety, as well as defining the dosing and application regiments of BoNT-B in the treatment of hyperhidrosis. Moreover, recent studies have been examining its safety profile, which may be different from those known about BoNT-A. The aim of this review is to provide information about what is currently known about BoNT-B in regards to the treatment of focal hyperhidrosis. MDPI 2023-02-11 /pmc/articles/PMC9966525/ /pubmed/36828461 http://dx.doi.org/10.3390/toxins15020147 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Campanati, Anna
Diotallevi, Federico
Radi, Giulia
Martina, Emanuela
Marconi, Barbara
Bobyr, Ivan
Offidani, Annamaria
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review
title Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review
title_full Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review
title_fullStr Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review
title_full_unstemmed Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review
title_short Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative Review
title_sort efficacy and safety of botulinum toxin b in focal hyperhidrosis: a narrative review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966525/
https://www.ncbi.nlm.nih.gov/pubmed/36828461
http://dx.doi.org/10.3390/toxins15020147
work_keys_str_mv AT campanatianna efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview
AT diotallevifederico efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview
AT radigiulia efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview
AT martinaemanuela efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview
AT marconibarbara efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview
AT bobyrivan efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview
AT offidaniannamaria efficacyandsafetyofbotulinumtoxinbinfocalhyperhidrosisanarrativereview

Ejemplares similares